I/VC  Forward Ventures


     Office Locations:

4747 Executive Dr., Suite 700
San Diego, CA 92121
Phone: 858-677-6077
Fax: 858-452-8799



  • Early
  • Seed



  • Life Sciences & Healthcare
  • Medical Device



    Forward Ventures, founded in 1990, has a team of investment professionals with extensive experience in entrepreneurship, venture capital, biological sciences, operations, and corporate management. The most recent fund focuses on biopharmaceutical products in early clinical development. On a number of occasions, Forward has seeded companies from scratch, building strong teams to pursue compelling opportunities.The firm is located in San Diego, an elite biomedical research and innovation community and one of the nation’s top biotechnology centers for commercialization. Though headquartered in San Diego, the firm has sourced assets and technologies globally and invested throughout the United States. The firm is headquartered in a 40,000 square-foot research building that also serves as an incubator for its portfolio companies. Forward invests in companies of all stages of development in North America and will consider select European opportunities. Its typical investment size ranges from $1 to $6 million (initially), and $3 to $15 million over the total lifespan of the investment. The firm's Forward Pacific Ventures team focuses on China opportunities.



      Fund Name



    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription or Southern California Database subscription.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Southern California Database subscription.
    Caroline Barberio Chief Financial Officer
    Standish Fleming MBA Founding Managing Partner
    Stuart J.M. Collinson PhD Partner


    Portfolio companies include:

      Acorda Therapeutics
        web link


      Affinium Pharmacueticals
        web link

      Ambit Biosciences
        web link

        web link

      Avalon Pharmaceuticals
        web link

      Cabrellis Pharmaceuticals

        web link

      Essentials Therapeutics
        web link

      HemaQuest Pharmacueticals
        web link


      Ligocyte Pharmacueticals
        web link

        web link

      MMR Information Systems
        web link


        web link

        web link

        web link

      Onyx Pharmaceuticals

      Proprius Pharmacueticals
        web link

      Sequel Pharmacueticals
        web link

      Syndax Pharmaceuticals
        web link


      Tioga Pharmaceuticals
        web link

      Viracta Therapeutics
        web link


    Recent News: